Evidence map›Paper›PMID 38116562›Full record

ArticleIranian journal of pharmaceutical research : IJPR

In vitro Evaluation of the Potent Antileishmanial Activity of

Shaylin Saraei, Narges Soozangar, Mansour Miran, Fatemeh Ghaffarifar, Behnam Mohammadi-Ghalehbin, Soheila Molaei, Shabnam Asfaram

Open access · hybridAbstract read
PubMed Full text at PMC Publisher
In one paragraph

Article in Iranian journal of pharmaceutical research : IJPR. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 2 papers.

0numbers the graph read from it
0cells of the map it votes in
2citing papers in PubMed
0.2field-weighted citation impact, top 42% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

2 citing papers in PubMed, 1 citations in OpenAlex.

  1. Article
  2. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

7 authors at 2 institutions in 1 country.

Shaylin Saraei *Students Research Committee, School of Medicine, Ardabil University of Medical Sciences, Ardabil, Iran.ORCID https://orcid.org/0009-0003-0694-6120
Narges Soozangar *Zoonoses Research Center, Ardabil University of Medical Sciences, Ardabil, Iran.ORCID https://orcid.org/0000-0002-9404-4033
Mansour MiranDepartment of Pharmacognosy and Biotechnology, School of Pharmacy, Ardabil University of Medical Sciences, Ardabil, Iran.ORCID https://orcid.org/0000-0002-3156-9123
Fatemeh GhaffarifarDepartment of Parasitology, Faculty of Medical Sciences, Tarbiat Modares University, Tehran, Iran.
Behnam Mohammadi-GhalehbinZoonoses Research Center, Ardabil University of Medical Sciences, Ardabil, Iran.ORCID https://orcid.org/0000-0002-4788-323X
Soheila MolaeiZoonoses Research Center, Ardabil University of Medical Sciences, Ardabil, Iran.ORCID https://orcid.org/0000-0001-9262-4504
Shabnam AsfaramZoonoses Research Center, Ardabil University of Medical Sciences, Ardabil, Iran.ORCID https://orcid.org/0000-0002-4455-1512
Ardabil University of Medical Sciences · IRTarbiat Modares University · IR

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Background: The available drugs for the treatment of leishmaniasis are highly toxic and extremely expensive, with low efficiency; therefore, the development of effective therapeutic compounds is essential. Objectives: The present study aimed to explore the antileishmanial effects of ethyl acetate extract, methanol extract, and fractions 1-4 (F1-F4) of Methods: In this study, ethyl acetate, methanol, and n-hexane extracts were extracted from the aerial roots of Results: The results indicated the highly potent activity of Conclusions: In this study, the F1 fraction and methanol extract of

Indexed as

Ethyl Acetate ExtractFerula tabasensisFractionIn vitroLeishmania majorMethanol ExtractShark Cartilage Extract

Identifiers

PMID38116562
PMCPMC10728847
OpenAlexW4383373955

What Socratic holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.